Cas:156764-82-8 Hosenkoside B manufacturer & supplier

Chemical Name:Hosenkoside B

CAS.NO:156764-82-8

Synonyms:(1R,2S,4aR,4bR,6’R,6aR,7R,8S,10aR,10bR,12aS)-6′-[(2R)-1-(β-D-Glucopyranosyloxy)-2-propanyl]-1-hydroxy-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyloctadecahydro-1H,4’H-spiro[chrysene-2,3′-pyran]-8-yl 2 -O-β-D-glucopyranosyl-β-D-glucopyranoside;β-D-Glucopyranoside, (1R,2S,4aR,4bR,6’R,6aR,7R,8S,10aR,10bR,12aS)-6′-[(1R)-2-(β-D-glucopyranosyloxy)-1-methylethyl]octadecahydro-1-hydroxy-7-(hydroxymethyl)-4a,4b,7,10a-tetramethylspiro[chrysene -2(1H),3′(4’H)-[2H]pyran]-8-yl 2-O-β-D-glucopyranosyl-;Hosenkoside B

Molecular Formula:C₄₈H₈₂O₂₀

Molecular Weight:979.153

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:1075.9±65.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.626

PSA:327.60000

Exact Mass:978.539917

LogP:0.18

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (1R,2S,4aR,4bR,6’R,6aR,7R,8S,10aR,10bR,12aS)-6′-[(2R)-1-(β-D-Glucopyranosyloxy)-2-propanyl]-1-hydroxy-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyloctadecahydro-1H,4’H-spiro[chrysene-2,3′-pyran]-8-yl 2 -O-β-D-glucopyranosyl-β-D-glucopyranoside chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hosenkoside B physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,2S,4aR,4bR,6’R,6aR,7R,8S,10aR,10bR,12aS)-6′-[(2R)-1-(β-D-Glucopyranosyloxy)-2-propanyl]-1-hydroxy-7-(hydroxymethyl)-4a,4b,7,10a-tetramethyloctadecahydro-1H,4’H-spiro[chrysene-2,3′-pyran]-8-yl 2 -O-β-D-glucopyranosyl-β-D-glucopyranoside Use and application,Hosenkoside B technical grade,usp/ep/jp grade.

Related News: Last year, California became the first state in the country to ban toxic chemicals in cosmetics — including a number of PFAS. Maryland did the same this month, but the laws don’t take effect until 2025, the Post reported. Hosenkoside B manufacturer Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei. Hosenkoside B supplier There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. Hosenkoside B vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. Hosenkoside B factory Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei.